DOV vs MRSN · P/E 27, rev $4.24B vs rev $40.5M
Dover Corporation (DOV) versus Mersana Therapeutics Inc (MRSN) — a side-by-side from cached financials, not a winner call.
Dover Corporation (DOV) is a specialty industrial machinery company listed on US.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
Latest reported DOV revenue for 2026-06-30 was $4.24B. Net income was $550.7M. DOV currently screens at market cap $28.92B and trailing P/E 26.8.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
DOV currently screens at market cap $28.92B and trailing P/E 26.8. MRSN currently screens at market cap $145.4M.
Not investment advice. Open the DOV and MRSN stock pages for the full models.
Not investment advice.